Stem cells therapy in cerebral palsy: A systematic review

Area of Science:

• Regenerative Medicine
• Pediatric Neurology
• Clinical Trials

Background:

• Cerebral palsy (CP) is a complex neurological disorder affecting motor function in children.
• Current treatments for CP focus on managing symptoms and improving quality of life.
• Stem cell therapy presents a potential novel therapeutic approach for CP.

Purpose of the Study:

• To systematically review and present the best available evidence on stem cell therapies for pediatric cerebral palsy.
• To analyze the efficacy and safety of different stem cell application methods in children with CP.

Main Methods:

• A comprehensive literature search was conducted across Medline, PubMed, EMBASE, and Cochrane Controlled Trials Register for studies from 1967 to August 2015.
• Included study designs encompassed systematic reviews, randomized controlled trials (RCTs), controlled trials, uncontrolled trials, cohort studies, open-label studies, and meta-analyses.
• Seven studies, including one RCT and six open-label trials, met the inclusion criteria.

Main Results:

• Stem cell therapy was administered as a single application in most studies, with cell doses ranging from 10^6 to 10^8 cells/kg.
• Motor development was the primary outcome measure in most studies; neuroimaging was used in three to confirm efficacy.
• Observation periods ranged from 3 months to 5 years, with generally good patient tolerance reported.

Conclusions:

• Stem cell therapy may offer benefits for certain symptoms in children with cerebral palsy.
• The current evidence suggests potential efficacy, but larger, robust studies are required to definitively establish the impact of stem cell therapy on CP.
• Further research is needed to optimize treatment protocols and confirm long-term outcomes.